Background: We hypothesized that a negative microvolt T-wave alternans (MTWA) test would identify patients unlikely to benefit from primary prevention implantable cardioverter defibrillator (ICD) therapy in a prospective cohort. Methods and Results: Data were pooled from 8 centers where MTWA testing was performed specifically for the purpose of guiding primary prevention ICD implantation. Cohorts were included if the ratio of ICDs implanted in patients who were MTWA "non-negative" to patients who were MTWA negative was >2:1, indicating that MTWA testing had a significant impact on the decision to implant an ICD. The pooled cohort included 651 patients: 371 MTWA non-negative and 280 MTWA negative. Among non-negative patients, 62% underwent ICD implantation whereas only 13% of MTWA-negative patients received an ICD (P<0.01). Despite a substantially lower prevalence of ICDs, long-term survival (6.9 years) was significantly better among MTWA-negative patients (68.2% non-negative vs. 87.1% negative, P=0.026). Conclusions: MTWA-negative patients had significantly better survival than MTWA non-negative patients, the majority of whom had ICDs. Despite a very low prevalence of ICDs, long-term survival among patients with left ventricular ejection fraction ≤40% and a negative MTWA test was better than in the ICD arm of any study to date that has demonstrated a benefit of ICDs. This provides further evidence that MTWA-negative patients are unlikely to benefit from primary prevention ICD therapy. © 2015, Japanese Circulation Society. All rights reserved.

Prospective use of microvolt T-wave alternans testing to guide primary prevention implantable cardioverter defibrillator therapy / Merchant, Faisal M; Salerno Uriarte, Jorge A.; Caravati, Fabrizio; Falcone, Stefania; Molon, Giulio; Marangoni, Daniele; Raczak, Grzegorz; Danilowicz Szymanowicz, Ludmila; Pedretti, Roberto F. E.; Braga, Simona Sarzi; Ikeda, Takanori; Calo, Leonardo; Martino, Annamaria; Erciyes, Demet; Piancastelli, Maurizio; Maury, Philippe; Cohen, Richard J.; Armoundas, Antonis A.. - In: CIRCULATION JOURNAL. - ISSN 1346-9843. - STAMPA. - 79:9(2015), pp. 1912-1919. [10.1253/circj.CJ-15-0253]

Prospective use of microvolt T-wave alternans testing to guide primary prevention implantable cardioverter defibrillator therapy

FALCONE, Stefania;MARTINO, ANNAMARIA;
2015

Abstract

Background: We hypothesized that a negative microvolt T-wave alternans (MTWA) test would identify patients unlikely to benefit from primary prevention implantable cardioverter defibrillator (ICD) therapy in a prospective cohort. Methods and Results: Data were pooled from 8 centers where MTWA testing was performed specifically for the purpose of guiding primary prevention ICD implantation. Cohorts were included if the ratio of ICDs implanted in patients who were MTWA "non-negative" to patients who were MTWA negative was >2:1, indicating that MTWA testing had a significant impact on the decision to implant an ICD. The pooled cohort included 651 patients: 371 MTWA non-negative and 280 MTWA negative. Among non-negative patients, 62% underwent ICD implantation whereas only 13% of MTWA-negative patients received an ICD (P<0.01). Despite a substantially lower prevalence of ICDs, long-term survival (6.9 years) was significantly better among MTWA-negative patients (68.2% non-negative vs. 87.1% negative, P=0.026). Conclusions: MTWA-negative patients had significantly better survival than MTWA non-negative patients, the majority of whom had ICDs. Despite a very low prevalence of ICDs, long-term survival among patients with left ventricular ejection fraction ≤40% and a negative MTWA test was better than in the ICD arm of any study to date that has demonstrated a benefit of ICDs. This provides further evidence that MTWA-negative patients are unlikely to benefit from primary prevention ICD therapy. © 2015, Japanese Circulation Society. All rights reserved.
2015
Implantable cardioverter defibrillator; Microvolt T wave alternans; Primary prevention; Risk stratification; Sudden cardiac death; Cardiology and Cardiovascular Medicine
01 Pubblicazione su rivista::01a Articolo in rivista
Prospective use of microvolt T-wave alternans testing to guide primary prevention implantable cardioverter defibrillator therapy / Merchant, Faisal M; Salerno Uriarte, Jorge A.; Caravati, Fabrizio; Falcone, Stefania; Molon, Giulio; Marangoni, Daniele; Raczak, Grzegorz; Danilowicz Szymanowicz, Ludmila; Pedretti, Roberto F. E.; Braga, Simona Sarzi; Ikeda, Takanori; Calo, Leonardo; Martino, Annamaria; Erciyes, Demet; Piancastelli, Maurizio; Maury, Philippe; Cohen, Richard J.; Armoundas, Antonis A.. - In: CIRCULATION JOURNAL. - ISSN 1346-9843. - STAMPA. - 79:9(2015), pp. 1912-1919. [10.1253/circj.CJ-15-0253]
File allegati a questo prodotto
File Dimensione Formato  
Merchant_Prospective_2015.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 953.7 kB
Formato Adobe PDF
953.7 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/852386
Citazioni
  • ???jsp.display-item.citation.pmc??? 8
  • Scopus 15
  • ???jsp.display-item.citation.isi??? 12
social impact